Cargando…

Neuromodulation for treatment-resistant depression

Treatment-resistant depression affects at least 1-3% of the US population. This article reviews the current state of focal neuromodulation therapies for treatment-resistant depression, focusing on those treatments published clinical data. These include transcranial magnetic stimulation, transcranial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holtzheimer, Paul E., Mayberg, Helen S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculty of 1000 Ltd 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506219/ https://www.ncbi.nlm.nih.gov/pubmed/23189091 http://dx.doi.org/10.3410/M4-22

Ejemplares similares

CORRIGENDUM TO: Neuromodulation for treatment-resistant depression
por: Holtzheimer, Paul E., et al.
Publicado: (2012)

Whole Brain Network effects of subcallosal cingulate deep brain stimulation for treatment-resistant depression
por: Cha, Jungho, et al.
Publicado: (2023)

Update on Neuromodulation for Treatment-Resistant Depression
por: Bewernick, Bettina, et al.
Publicado: (2015)

Neuromodulation therapies and treatment-resistant depression
por: Al-Harbi, Khalid Saad, et al.
Publicado: (2012)

A connectomic approach for subcallosal cingulate deep brain stimulation surgery: prospective targeting in treatment-resistant depression
por: Riva-Posse, Patricio, et al.
Publicado: (2017)

Deep brain stimulation in the treatment of depression
por: Delaloye, Sibylle, et al.
Publicado: (2014)

Neuromodulation and antenatal depression: a review
por: Kim, Deborah R, et al.
Publicado: (2015)

Neuromodulation in Drug Resistant Epilepsy
por: Rincon, Natalia, et al.
Publicado: (2021)

Neuromodulation for treatment-resistant depression: Functional network targets contributing to antidepressive outcomes
por: Idlett-Ali, Shaquia L., et al.
Publicado: (2023)

Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression
por: Guo, Bingqi, et al.
Publicado: (2023)

Neuroimaging-based biomarkers for treatment selection in major depressive disorder
por: Dunlop, Boadie W., et al.
Publicado: (2014)

Future prospects in depression research
por: Holtzheimer III, Paul E., et al.
Publicado: (2006)

Stimulation and Neuromodulation in the Treatment of Epilepsy
por: Eastin, Timothy Marc, et al.
Publicado: (2017)

Neuroimaging Advances for Depression
por: Dunlop, Boadie W., et al.
Publicado: (2017)

Developing a New Neuromodulation Treatment Pathway for the Treatment of Depression
por: Papadopoulos, Andreas, et al.
Publicado: (2022)

Views about neuromodulation interventions for depression by stakeholder group, treatment modality, and depression severity
por: Cabrera, L.Y., et al.
Publicado: (2023)

Characterizing the therapeutic response to deep brain stimulation for treatment-resistant depression: a single center long-term perspective
por: Crowell, Andrea L., et al.
Publicado: (2015)

Towards a multilevel model of major depression: genes, immuno-metabolic function, and cortico-striatal signaling
por: Paul, Elisabeth R., et al.
Publicado: (2023)

Deep Brain Stimulation Neuromodulation for the Treatment of Mood Disorders: Obsessive Compulsive Disorder and Treatment Resistant Depression
por: Marquez-Franco, Rene, et al.
Publicado: (2022)

Emerging Trends in Neuromodulation for Treatment of Drug-Resistant Epilepsy
por: Abouelleil, Mohamed, et al.
Publicado: (2022)

Neuromodulation for the Treatment of Heart Rhythm Disorders
por: Waldron, Nathan H., et al.
Publicado: (2019)

Movement Disorders and Neuromodulation
por: Shipton, Edward A.
Publicado: (2012)

Neuromodulation in neurogenic bladder
por: Sanford, Melissa T., et al.
Publicado: (2016)

Penile Rehabilitation and Neuromodulation
por: Facio, Fernando, et al.
Publicado: (2009)

Neuromodulation for Trigeminal Neuralgia
por: Chung, Moonyoung, et al.
Publicado: (2022)

Neuromodulation for Refractory Epilepsy
por: Ryvlin, Philippe, et al.
Publicado: (2021)

Network effects of Stanford Neuromodulation Therapy (SNT) in treatment-resistant major depressive disorder: a randomized, controlled trial
por: Batail, Jean-Marie, et al.
Publicado: (2023)

Pelvic Electrical Neuromodulation for the Treatment of Overactive Bladder Symptoms
por: Al-Shaiji, Tariq F., et al.
Publicado: (2011)

REAC Neuromodulation Treatments in Depression, Anxiety and Stress. A Comparative Retrospective Study
por: Pinheiro Barcessat, Ana Rita, et al.
Publicado: (2020)

Longitudinal Changes in Depressive Circuitry in Response to Neuromodulation Therapy
por: Pathak, Yagna, et al.
Publicado: (2016)

Suicidality during neuromodulation in the elderly depressed: study design
por: Van Daele, A., et al.
Publicado: (2022)

Neuromodulation for Pelvic and Urogenital Pain
por: Roy, Holly, et al.
Publicado: (2018)

Non-Invasive Neuromodulation for Tinnitus
por: Langguth, Berthold
Publicado: (2020)

The Use of Neuromodulation for Symptom Management
por: Farrell, Sarah Marie, et al.
Publicado: (2019)

Strategies for precision vagus neuromodulation
por: Ahmed, Umair, et al.
Publicado: (2022)

Safety of Clinical Ultrasound Neuromodulation
por: Radjenovic, Sonja, et al.
Publicado: (2022)

Neuromodulation in eating disorders and obesity: a promising way of treatment?
por: Jáuregui-Lobera, Ignacio, et al.
Publicado: (2018)

Peripheral Neuromodulation for the Management of Headache
por: Urits, Ivan, et al.
Publicado: (2020)

The Evolution of Neuromodulation in the Treatment of Chronic Pain: Forward-Looking Perspectives
por: Fishman, Michael A, et al.
Publicado: (2019)

Neurocognitive Predictors of Response in Treatment Resistant Depression to Subcallosal Cingulate Gyrus Deep Brain Stimulation
por: McInerney, Shane J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jjvlvn03cbqg1g8dcor8fo60bc